FUJIFILM Biotechnologies Named a 2026 CDMO Leadership Award Winner

NEW YORK--(BUSINESS WIRE)--FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced that it has been named a 2026 CDMO Leadership Awards winner in the category of Most Innovative CDMO (Biologics). The CDMO Leadership Awards, presented by Outsourced Pharma and Life Science Connect, are based on direct feedback from biopharma sponsors who have worked with CDMOs over the past 18–24 months.